Wooridul Pharmaceutical Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Wooridul Pharmaceutical Limited with three other
companies in this sector in South Korea:
Sam-A Pharmaceutical Company
sales of 65.88 billion Korean Won [US$58.89 million]
Daebong LS Company Limited
(71.04 billion Korean Won [US$63.51 million]
of which 89%
was Manufacturing), and
Ilsung Pharmaceuticals Company Limited
(67.46 billion Korean Won [US$60.31 million]
of which 100%
was Pharmaceutical Business).
During the year ended December of 2016, sales at
Wooridul Pharmaceutical Limited were 71.55 billion Korean Won (US$63.96 million).
increase of 18.4%
versus 2015, when the company's sales were 60.41 billion Korean Won.
This was the fifth consecutive year of sales increases at Wooridul Pharmaceutical Limited
(and since 2011, sales have increased a total of 156%).